TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026)
TherapeuticsMD (TXMD) posted Interest & Investment Income of $41000.0 for Q1 2026, up 41.38% on a QoQ basis from $29000.0 in Q1 2025, and up 41.38% year-over-year from $29000.0 in Q1 2025.
TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
TherapeuticsMD's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $41000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 41.38% year-over-year to $41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70000.0 (up 113.21% YoY) and the FY2025 annual result came in at $142000.0, up 5.19% from the prior year.
- Interest & Investment Income was $41000.0 for Q1 2026 at TherapeuticsMD, up from $29000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $41000.0 in Q1 2026 and bottomed at $29000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Jun 30, 2017 | 3,832.00 |
| Mar 31, 2017 | 3,867.00 |
| Jun 30, 2016 | 2,863.00 |
| Mar 31, 2016 | 2,536.00 |
| Dec 31, 2015 | -6,111.00 |
| Sep 30, 2015 | 2,760.00 |
| Mar 31, 2015 | 18,513.00 |
| Dec 31, 2014 | 9,553.00 |
| Sep 30, 2014 | 9,364.00 |